PMID: 11903505Mar 21, 2002Paper

Isoniazid pharmacokinetics in children according to acetylator phenotype

Fundamental & Clinical Pharmacology
E ReyG Pons

Abstract

The pharmacokinetics of isoniazid (INH) was studied in children (0-196 months old) according to their acetylator phenotype, estimated from the metabolic acetyl INH/INH molar plasma concentration ratio (MR) measured 3 h after INH oral administration. There were 17 slow (MR < 0.48) and 17 fast acetylators (MR > or = 0.48). The mean apparent plasma clearance was significantly lower, the mean apparent volume of distribution higher and the half-life longer in the slow acetylator group (C1, 0.298 +/- 0.099 L/h/kg; Vd, 1.56 +/- 0.65 L/kg; t1/2, 3.88 +/- 01.89 h) than in the fast acetylator group (Cl, 0.528 +/- 0.234 L/h/kg; Vd, 1.06 +/- 0.45; t1/2, 1.64 +/- 1.1 h). The half-life decreased with age. An impaired isoniazid elimination was suggested in children less than three months old, which may be in favour of an individual dose adjustment in this population.

References

Nov 1, 1979·Clinical Pharmacokinetics·W W Weber, D W Hein
Jan 1, 1986·European Journal of Clinical Pharmacology·M F KerguerisC Larousse
Aug 1, 1980·British Journal of Clinical Pharmacology·C AdvenierJ P Tillement
Dec 1, 1993·Clinical Pharmacology and Therapeutics·Y G KimY N Cha
Nov 14, 1997·Clinical Pharmacology and Therapeutics·A Pariente-KhayatG Pons
Mar 5, 1998·Therapeutic Drug Monitoring·E ReyD Gendrel
Oct 21, 1998·Therapeutic Drug Monitoring·W W Yew
Sep 25, 1999·Clinical Pharmacokinetics·J G Douglas, M J McLeod

❮ Previous
Next ❯

Citations

Jun 15, 2012·Therapeutic Drug Monitoring·Jennifer J KiserCourtney V Fletcher
May 24, 2005·Archives of Disease in Childhood·H S SchaafP R Donald
Apr 7, 2012·Clinical Radiology·Z I HasilogluN Kocer
Mar 1, 2012·The Lancet Infectious Diseases·James A SeddonH Simon Schaaf
Feb 5, 2008·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Michael HawkesDat Tran
May 30, 2009·Pharmacotherapy·Gail D Anderson, Anne M Lynn
Oct 10, 2008·Clinical Pharmacology and Therapeutics·M J KennedyG L Kearns
May 12, 2011·Journal of Clinical Pharmacology·Rui ZhuCourtney V Fletcher
Feb 5, 2014·Antimicrobial Agents and Chemotherapy·A BekkerA C Hesseling
Sep 11, 2007·Biopharmaceutics & Drug Disposition·Helen M BaldanRosângela G P Machado
Dec 2, 2005·Journal of Pharmacokinetics and Pharmacodynamics·Peter BuchwaldNicholas Bodor
Mar 28, 2019·Indian Journal of Pediatrics·Aparna MukherjeeS K Kabra
Nov 4, 2020·Antimicrobial Agents and Chemotherapy·Navarat PanjasawatwongJoel Tarning

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.